{"id":14872,"date":"2020-11-18T06:34:54","date_gmt":"2020-11-17T17:34:54","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=14872"},"modified":"2020-11-18T06:34:54","modified_gmt":"2020-11-17T17:34:54","slug":"cll-advocates-nz-newsletter-issue-6","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=14872","title":{"rendered":"CLL Advocates NZ Newsletter Issue 6"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”3″ bottom_padding=”3″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″][vc_custom_heading heading_semantic=”h1″ text_size=”h1″]<\/p>\n

CLL Advocates NZ Newsletter Issue 6<\/h1>\n

[\/vc_custom_heading][vc_column_text]Friends of CLLANZ<\/p>\n

Funding has been received, with thanks, from the BOP Medical Research Trust for a research project to be done as a summer studentship, by fifth year medical student, Andrew Weston, on \u201csecond primary malignancies in NZ CLL patients\u201d.<\/p>\n

Second primary malignancies are important in CLL, where the impaired immune system is not as able to deal to developing malignancies as people with normal immune systems can. As a consequence, about one third of CLL patients die of a second primary malignancy, such as melanoma, colon cancer, and pancreatic cancer. Some of these cancers have well-recognised screening procedures to detect early stage cancers, which can have a better outcomes to treatment then, compared to when they are picked up when symptoms develop.<\/p>\n

Regular skin checks, and colonoscopy are two good examples of this screening approach.<\/p>\n

I would be interested to hear from any of the CLLANZ Friends who are in this group i.e.\u00a0have had a second primary malignancy, as it may help with the study.\u00a0<\/strong><\/p>\n

I encourage you to spread the word about the existence of CLLANZ to any New Zealanders you know who are living with CLL, and encourage them to make contact with us.<\/p>\n

The other request is to encourage you all to take an active approach to our Facebook group, and to continue to read\u00a0HealthUnlocked<\/a>\u00a0and\u00a0Patient Power<\/a>\u00a0newsletters , which are both easy groups to join, or can be read on our website.<\/p>\n

A CLLANZ trustees meeting will be held this month, to review the year gone by, and to plan for the next twelve months. Please contact me at\u00a0neil@clladvocates.nz<\/a>\u00a0to let me know about any topics you would like considered for the agenda.<\/p>\n

Best wishes<\/p>\n

Neil Graham[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Welcome to issue 6 of the CLL Advocates newsletter. This month’s newsletter shares our latest update and asks for input into our upcoming Trustees meeting.<\/p>\n","protected":false},"author":1,"featured_media":1944,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[12,17,21],"tags":[],"class_list":["post-14872","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","category-featured","category-newsletter"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2020\/06\/CLLANZ-Favicon.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/14872","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14872"}],"version-history":[{"count":1,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/14872\/revisions"}],"predecessor-version":[{"id":14873,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/14872\/revisions\/14873"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/1944"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}